What the Name Change from PCOS to PMOS Really Means 

Polycystic ovary syndrome, PCOS, is now named polyendocrine metabolic ovarian syndrome, or PMOS. The change, published in The Lancet on May 12, 2026, was a global effort and involved over 22,000 patients, clinicians, researchers, and advocates from across the world. 

I’ve lived with PCOS, now PMOS for 20 years and I spent a lot of that time needlessly suffering with a whole range of symptoms and struggling to find a treatment plan that actually worked. I’m hoping the shift could change how the condition is diagnosed, researched, and treated. 

Why was PCOS changed to PMOS?

The main reason PCOS was renamed is because it’s completely inaccurate.

"Polycystic" implies the presence of pathological ovarian cysts, but we don’t actually have cysts at all.  What appears on ultrasound as "cysts" are immature follicles, underdeveloped egg sacs that didn’t release an egg. And not all women with PCOS have polycystic ovaries. In fact, it’s just one diagnostic criteria, along with irregular periods and high levels of androgens. So, you can have polycystic ovaries without having PMOS.

On top of that, PMOS affects our insulin levels, cardiovascular health, and more. It goes beyond just a narrow focus on ovaries and reproductive function. 

I have polycystic ovaries. I also have PMOS. These are not the same thing but not everyone in a clinical setting seems to know that yet.

I remember sitting in front of a gynaecologist, hoping for joined-up care, and being told that I have polycystic ovaries, not PCOS. End of. She had looked at my imaging and drawn her own conclusions without really understanding the full picture.

By that time, I had become so used to doctors not fully understanding PCOS. I wasn’t completely taken off guard. I had to walk her through my own history. The missed periods and the elevated androgen levels that had shown up clearly. Then I outlined the raft of lifestyle changes I had put in place over the years: exercise, a low carb diet, and a cabinet full of PCOS supplements. I'd also tracked my symptoms for years and had a solid picture of my own triggers.

I had done enougn of my own research and understood that my hormonal and metabolic picture needed active management. After years of study and trial and eror, I had become an expert in my own health. I knew that simply throwing birth control pills at the problem wasn’t a sustainable solution, not for me at least.  Sadly, this is not a rare experience. It is a defining one for many people with PMOS because the condition is so poorly understood across clinical settings. According to the global consensus report, up to 70% of people with the condition remain undiagnosed. One in eight women is estimated to have PMOS, making it one of the most common endocrine disorders on the planet. Yet a lot of us are walking around without answers or treatment.

The gynaecologist who told me I didn't have PCOS because my ovaries "only" showed polycystic morphology was not a bad doctor. She received her training in a framework built around a misleading name. 

PMOS presents differently in different bodies. It can look like irregular periods, or it can look like perfectly regular ones. In my case, I went months without periods until I started managing my symptoms naturally. Some people with PMOS see it show up as weight gain but lean PCOS exists too. It presents with acne, or with none. It causes infertility in some and presents no fertility issues in others until someone starts trying to conceive. 

It’s early days but I’m hopeful that PMOS might finally give the medical community the message that we’re dealing with a complex condition that goes beyond missed periods and infertility.

What PMOS Actually Is

The new name tells the truth about the condition. That is, that it’s more than a gynecological problem that interferes with periods and ovulation.

Polyendocrine accounts for that fact multiple hormones are involved, including androgens (like testosterone), insulin, and gonadotropins (LH/FSH). Referencing metabolic in the new name acknowledges the high risk of insulin resistance, type 2 diabetes, weight gain, and cardiovascular issues.

PMOS keeps ovarian because it maintains the connection to the reproductive system, irregular ovulation, and fertility without overplaying the role of cysts. 

Finally, PMOS is being seen for it is. A condition characterised by fluctuations in hormones, with effects on weight, metabolic health, skin, fertility, mental health, and the reproductive system. It is not a gynaecological problem. But if you’ve ever consulted with a doctor to treat your symptoms, you might already have been prescribed birth control as a first line treatment with little to no discussion on the far reaching health problems associated with PMOS. We’re at higher risk for all sorts of serious health problems like stroke and diabetes, and these risks remain even after our reproductive years are over.

Why the endocrine framing matters

Endocrine disorders attract a different quality of research attention than gynaecological ones. The sad reality is that research into women’s health has been historically underfunded.

But conditions framed as hormonal and metabolic are more likely to be studied in cardiometabolic contexts. These diseases have a higher chance of receiving funding from institutions focused on diabetes and metabolic disease.

Therefore, framing PMOS alongside conditions like thyroid disease, adrenal disorders, and type 2 diabetes could open doors to new research collaborations and treatment plans.

The Lancet paper itself notes that the previous terminology was "curtailing research and policy framing." The name PCOS was limiting the questions researchers thought to ask and the funding bodies that took notice. Not only that, but it was excluding a whole bench of specialists who felt the condition was not theirs to treat because it was placed so firmly in gynaecology.

As one researcher noted in announcing the change, the new name "opens doors for treatments that target the underlying metabolic causes, such as managing insulin resistance, to restore spontaneous ovulation and improve pregnancy outcomes." 

What Still Needs to Happen

A name change is only meaningful if it translates into better clinical care. That means diagnostic criteria need to reflect the condition's full range of presentations, not just its cystic or reproductive features. Doctors also need training to recognise PMOS in a patient even if she doesn’t fit the typical profile, for example in the case of lean PCOS. Treatments should also be updated to include screening to monitor and treat insulin resistance.

‍